We are live on ! Find out more
IMMU

Immunomedics Inc
IMMU

Delisted

IMMU was delisted on the 22nd of October, 2020.

Back to rankings

192 hedge funds and large institutions have $3.48B invested in Immunomedics Inc in 2018 Q2 according to their latest regulatory filings, with 44 funds opening new positions, 79 increasing their positions, 51 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed

132% more first-time investments, than exits

New positions opened: 44 | Existing positions closed: 19

90% more capital invested

Capital invested by funds: $1.83B → $3.48B (+$1.65B)

55% more repeat investments, than reductions

Existing positions increased: 79 | Existing positions reduced: 51

14% more funds holding

Funds holding: 168 → 192 (+24)

13% more funds holding in top 10

Funds holding in top 10: 8 → 9 (+1)

36% less call options, than puts

Call options by funds: $118M | Put options by funds: $184M

Holders
192
Holders Change
+24
Holders Change %
+14.29%
% of All Funds
4.39%
Holding in Top 10
9
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+12.5%
% of All Funds
0.21%
New
44
Increased
79
Reduced
51
Closed
19
Calls
$118M
Puts
$184M
Net Calls
-$65.4M
Net Calls Change
-$72.2M

Top Buyers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
+$113M
2
RCM
RA Capital Management
Massachusetts
+$62.7M
3
BlackRock
BlackRock
New York
+$44.1M
4
Alkeon Capital Management
Alkeon Capital Management
New York
+$37.2M
5
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$36M

Top Sellers

Rank Fund Capital Flow
1
NMC
NEA Management Company
Maryland
-$40.5M
2
ACP
Acuta Capital Partners
California
-$22.1M
3
State Street
State Street
Massachusetts
-$20M
4
O
OrbiMed
New York
-$15.4M
5
ACH
ArrowMark Colorado Holdings
Colorado
-$12.8M
Name Holding Trade Value Shares
Change 		Change in
Stake
ProShare Advisors
101
ProShare Advisors
Maryland
$2.08M -$40.8K -2,028 -2%
Dimensional Fund Advisors
102
Dimensional Fund Advisors
Texas
$2.04M +$1.73M +86,097 New
AIG
103
American International Group
New York
$2.03M +$412K +20,520 +31%
AQR Capital Management
104
AQR Capital Management
Connecticut
$2.03M -$122K -6,090 -7%
SI
105
Shaker Investments
Ohio
$1.99M +$1.16M +57,615 +218%
IA
106
IFP Advisors
Florida
$1.97M -$497K -24,732 -23%
State Board of Administration of Florida Retirement System
107
State Board of Administration of Florida Retirement System
Florida
$1.88M -$804 -40 -0.1%
Renaissance Technologies
108
Renaissance Technologies
New York
$1.77M +$1.51M +75,007 New
Squarepoint
109
Squarepoint
New York
$1.56M +$551K +27,425 +71%
ERSOT
110
Employees Retirement System of Texas
Texas
$1.54M +$1.31M +65,000 New
SO
111
STRS Ohio
Ohio
$1.53M +$1.3M +64,551 New
Simplex Trading
112
Simplex Trading
Illinois
$1.46M -$209K -10,413 -14%
MIM
113
MetLife Investment Management
New Jersey
$1.43M +$213K +10,612 +21%
MLICM
114
Metropolitan Life Insurance Company (MetLife)
New York
$1.36M +$532K +26,471 +85%
SEI Investments
115
SEI Investments
Pennsylvania
$1.34M +$1.05M +52,172 +1,191%
EP
116
Eversept Partners
New York
$1.3M +$1.11M +55,000 New
PVI
117
Pura Vida Investments
New York
$1.19M +$1.01M +50,400 New
PVAM
118
Pacific View Asset Management
California
$1.16M +$623K +30,990 +170%
Legal & General Group
119
Legal & General Group
United Kingdom
$1.13M -$95.1K -4,733 -9%
HighTower Advisors
120
HighTower Advisors
Illinois
$1.05M -$193K -9,601 -18%
QIM
121
Quantitative Investment Management
Virginia
$1.05M +$894K +44,500 New
Principal Financial Group
122
Principal Financial Group
Iowa
$1.04M +$200K +9,932 +29%
TAM
123
Tocqueville Asset Management
New York
$1.03M +$121K +6,000 +16%
Neuberger Berman Group
124
Neuberger Berman Group
New York
$1.01M +$858K +42,685 New
MSL
125
Mackay Shields LLC
New York
$938K -$48.2K -2,400 -6%
3 4
5
6 7

IMMU Hedge Fund Activity: Q2 2018 in Review

192 of the 4,369 institutional investors tracked by Wall St. Rank reported a position in Immunomedics Inc (IMMU) for Q2 2018, worth a combined $3.48B — up 90% from $1.83B a quarter earlier.

Buyers outnumbered sellers: 44 funds opened new IMMU positions and 19 closed out — a net gain of 25 holders — while 79 added to existing stakes and 51 trimmed.

The largest buyer was Vanguard Group, adding an estimated $113M. The largest seller was NEA Management Company, exiting entirely with an estimated $40.5M sold.

  • 192 institutional investors held Immunomedics Inc (IMMU) as of Q2 2018, up from 168 in Q1 2018.
  • Funds reported $3.48B of Immunomedics Inc stock for Q2 2018, up 90% quarter-over-quarter.
  • 44 funds opened new Immunomedics Inc positions in Q2 2018 and 19 closed out, a net change of +25 holders.
  • The largest Immunomedics Inc buyer in Q2 2018 was Vanguard Group, an estimated $113M added.
  • The largest Immunomedics Inc seller in Q2 2018 was NEA Management Company, an estimated $40.5M sold.

Based on aggregated 13F filings for Q2 2018.